The company held the meetings to encourage open discussion on study protocols.
Vedic Lifesciences (Redwood Shores, CA) announced today that it recently held investigator meetings for two upcoming product studies on sexual dysfunction in men and women.
The meetings were held on November 28 and December 5 for the company’s Phase II Female Sexual Dysfunction study and Phase II Male Sexual Dysfunction study.
Both studies will be performed in India (where the company has its world headquarters) in multicenter, open-label, and placebo-controlled fashion.
Jayesh Chaudhary, the company’s managing director, urged for the clinical investigator meetings as opportunities to provide information on study protocol and Good Clinical Practice (GCP) training.